31901862|t|Tumor necrosis factor alpha-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-kappaB activation in hepatocellular carcinoma.
31901862|a|BACKGROUND: Tumor necrosis factor alpha-induced protein 1 (TNFAIP1) is frequently downregulated in cancer cell lines and promotes cancer cell apoptosis. However, its role, clinical significance and molecular mechanisms in hepatocellular carcinoma (HCC) are unknown. METHODS: The expression of TNFAIP1 in HCC tumor tissues and cell lines was measured by Western blot and immunohistochemistry. The effects of TNFAIP1 on HCC proliferation, apoptosis, metastasis, angiogenesis and tumor formation were evaluated by Cell Counting Kit-8 (CCK8), Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL), transwell, tube formation assay in vitro and nude mice experiments in vivo. The interaction between TNFAIP1 and CSNK2B was validated by liquid chromatography-tandem mass spectrometry (LC-MS/MS), Co-immunoprecipitation and Western blot. The mechanism of how TNFAIP1 regulated nuclear factor-kappaB (NF-kappaB) pathway was analyzed by dual-luciferase reporter, immunofluorescence, quantitative Real-time polymerase chain reaction (RT-qPCR) and Western blot. FINDINGS: The TNFAIP1 expression is significantly decreased in HCC tissues and cell lines, and negatively correlated with the increased HCC histological grade. Overexpression of TNFAIP1 inhibits HCC cell proliferation, metastasis, angiogenesis and promotes cancer cell apoptosis both in vitro and in vivo, whereas the knockdown of TNFAIP1 in HCC cell displays opposite effects. Mechanistically, TNFAIP1 interacts with CSNK2B and promotes its ubiquitin-mediated degradation with Cul3, causing attenuation of CSNK2B-dependent NF-kappaB trans-activation in HCC cell. Moreover, the enforced expression of CSNK2B counteracts the inhibitory effects of TNFAIP1 on HCC cell proliferation, migration, and angiogenesis in vitro and in vivo. INTERPRETATION: Our results support that TNFAIP1 can act as a tumor suppressor of HCC by modulating TNFAIP1/CSNK2B/NF-kappaB pathway, implying that TNFAIP1 may represent a potential marker and a promising therapeutic target for HCC.
31901862	57	62	tumor	Disease	MESH:D009369
31901862	110	116	CSNK2B	Gene	13001
31901862	124	145	nuclear factor-kappaB	Gene	18033
31901862	160	184	hepatocellular carcinoma	Disease	MESH:D006528
31901862	245	252	TNFAIP1	Gene	21927
31901862	285	291	cancer	Disease	MESH:D009369
31901862	316	322	cancer	Disease	MESH:D009369
31901862	408	432	hepatocellular carcinoma	Disease	MESH:D006528
31901862	434	437	HCC	Disease	MESH:D006528
31901862	479	486	TNFAIP1	Gene	21927
31901862	490	499	HCC tumor	Disease	MESH:D006528
31901862	593	600	TNFAIP1	Gene	21927
31901862	604	607	HCC	Disease	MESH:D006528
31901862	634	644	metastasis	Disease	MESH:D009362
31901862	663	668	tumor	Disease	MESH:D009369
31901862	725	762	Terminal deoxynucleotidyl transferase	Gene	21673
31901862	763	767	dUTP	Chemical	MESH:C027078
31901862	845	849	mice	Species	10090
31901862	895	902	TNFAIP1	Gene	21927
31901862	907	913	CSNK2B	Gene	13001
31901862	1052	1059	TNFAIP1	Gene	21927
31901862	1070	1091	nuclear factor-kappaB	Gene	18033
31901862	1093	1102	NF-kappaB	Gene	18033
31901862	1265	1272	TNFAIP1	Gene	21927
31901862	1314	1317	HCC	Disease	MESH:D006528
31901862	1387	1390	HCC	Disease	MESH:D006528
31901862	1429	1436	TNFAIP1	Gene	21927
31901862	1446	1449	HCC	Disease	MESH:D006528
31901862	1470	1480	metastasis	Disease	MESH:D009362
31901862	1508	1514	cancer	Disease	MESH:D009369
31901862	1582	1589	TNFAIP1	Gene	21927
31901862	1593	1596	HCC	Disease	MESH:D006528
31901862	1646	1653	TNFAIP1	Gene	21927
31901862	1669	1675	CSNK2B	Gene	13001
31901862	1729	1733	Cul3	Gene	26554
31901862	1758	1764	CSNK2B	Gene	13001
31901862	1775	1784	NF-kappaB	Gene	18033
31901862	1805	1808	HCC	Disease	MESH:D006528
31901862	1852	1858	CSNK2B	Gene	13001
31901862	1897	1904	TNFAIP1	Gene	21927
31901862	1908	1911	HCC	Disease	MESH:D006528
31901862	2023	2030	TNFAIP1	Gene	21927
31901862	2044	2049	tumor	Disease	MESH:D009369
31901862	2064	2067	HCC	Disease	MESH:D006528
31901862	2082	2089	TNFAIP1	Gene	21927
31901862	2090	2096	CSNK2B	Gene	13001
31901862	2097	2106	NF-kappaB	Gene	18033
31901862	2130	2137	TNFAIP1	Gene	21927
31901862	2210	2213	HCC	Disease	MESH:D006528
31901862	Negative_Correlation	MESH:D009362	21927
31901862	Association	21927	26554
31901862	Association	13001	21927
31901862	Positive_Correlation	13001	18033
31901862	Association	18033	21927
31901862	Association	MESH:D009369	18033
31901862	Negative_Correlation	MESH:D009369	21927
31901862	Association	MESH:D006528	18033
31901862	Negative_Correlation	MESH:D006528	21927
31901862	Association	MESH:D009369	13001
31901862	Association	MESH:D006528	13001

